Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Publication
Video
Dermatology Times
Dermatology Times, August 2020 (Vol. 41, No. 8)Volume41 Issue 8
What’s new in noninvasive body contouring?
Author(s):
At the most recent ASDS meeting, Catherine DiGiorgio, M.D., Boston, discusses the current state of noninvasive body contouring, and what noninvasive devices and procedures will soon hit the market including a collagenase clostridium histolyticum injection and cellulite-targeting devices that use electromagnetic stimulation and radiofrequency
Articles in this issue
Survey findings inform messaging on UV exposure
Studies examine ingredient safety over lifetime use
Pilot study examines facial microbiome diversity
Topical minocycline foam safe, well-tolerated
How to eat for healthy skin
Skin microbiome altered in some rosacea subtypes
A new business model for dermatology
Is Covid-19 a defense to a battery charge?
A ‘biomarker’ of psychiatric adverse effects with isotretinoin?
Researchers encourage reporting on hormone therapy in acne trial demographics
Immune checkpoint inhibitor therapy advances treatment for Merkel cell carcinoma
First injectable for cellulite approved by FDA
Proprietary supplements largely unnecessary
PRP increasing in popularity for periorbital rejuvenation
Nanotechnology: An opportunity to advance skin cancer treatment
Related Videos
Related Content
